Oral Session 1-7C Multiple Myeloma: Multicenter Clinical Trials

[OS1-7C-1] Real-world outcomes of ixazomib: a multicenter retrospective analysis from Kansai Myeloma Forum

Teruhito Takakuwa¹, Ryosuke Yamamura¹, Kensuke Ohta², Hitomi Kaneko³, Kazunori Imada³, Aya Nakaya⁴, Shinichi Fuchida⁵, Hirohiko Shibayama⁶, Mitsuhiro Matsuda⁷, Yutaka Shimazu⁸, Yoko Adachi⁹, Satoru Kosugi¹⁰, Hitoji Uchiyama¹¹, Hirokazu Tanaka¹², Hitoshi Hanamoto¹³, Yuji Shimura¹⁴, Junya Kanda¹⁵, Yoshiyuki Onda¹⁵, Nobuhiko Uoshima¹⁶, Hideo Yagi¹⁷, Satoshi Yoshihara¹⁸, Masayuki Hino¹⁹, Chihiro Shimazaki⁵, Akifumi Takaori¹⁵, Junya Kuroda¹⁴, Itaru Matsumura¹², Yuzuru Kanakura⁶, Shosaku Nomura⁴ (1.Department of Hematology, Osaka Saiseikai Nakatsu Hospital, 2.Hematology Ohta Clinic, Shinsaibashi, 3.Department of Hematology, Japanese Red Cross Osaka Hospital, 4.Hematol., Kansai Medical University Medical Center, 5.Hematol., Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, 6.Hematol. and Oncol., Osaka University Graduate School of Medicine, 7.Department of Hematology, PL General Hospital, 8.Hematol., Japanese Red Cross Wakayama Medical Center, 9.Department of Internal Medicine, JCHO Kobe Central Hospital, 10.Department of Internal Medicine (Hematology), Toyonaka Municipal Hospital, 11.Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, 12.Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, 13.Department of Hematology, Kindai University Nara Hospital, 14.Hematol. and Oncol., Kyoto Prefectural University of Medicine, 15.Hematol. and Oncol., Graduate School of Medicine, Kyoto University, 16.Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, 17.Hematol. and Oncol., Nara Prefecture General Medical Center, 18.Hematol., Hyogo College of Medicine, Department of Internal Medicine, 19.Hematol., Osaka City University Graduate School of Medicine)